Clinical trial

Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy

NCT07307911

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-11-10

PhasePHASE2

Study timeline

Study start (actual)2025-11-10Date precision: day

Registry last updated2026-04-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Coenzyme Q 10DIETARY_SUPPLEMENT

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Sponsors & collaborators

Damanhour Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07307911 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.